Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase NA × Breast Neoplasm Female × pyrotinib × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 3 HER2-positive Breast Cancer 1 HER2 Positive Breast Cancer 1 Colorectal Neoplasms 1 Breast Neoplasm Female 1 Breast Diseases 1 Breast Cancer Female 1

Interventions

pyrotinib 1 Ropivacaine 1 Radiosurgery 1 Propofol 1 Ondansetron 1 Morphine 1 Etoricoxib 1 Docetaxel 1 Diagnostic Imaging 1 Carboplatin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06234137 2024-01-31

neoPICD

First Affiliated Hospital of Wenzhou Medical University

Phase NA Recruiting

Breast Neoplasm Female

Data powered by HemOnc (CC BY 4.0) Colophon ⚡